TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 SEK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
319,183
|
330,221
|
434,633 |
| Financial expenses |
899
|
931
|
1,411 |
| Earnings before taxes |
12,475
|
26,219
|
7,848 |
| EBITDA |
12,618
|
26,222
|
9,518 |
| Total assets |
329,544
|
378,079
|
248,809 |
| Current assets |
329,543
|
377,989
|
248,536 |
| Current liabilities |
138,018
|
195,867
|
87,134 |
| Equity capital |
76,526
|
67,212
|
46,675 |
| - share capital |
200
|
200
|
200 |
| Employees (average) |
34
|
38
|
46 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
23.2%
|
17.8%
|
18.8% |
| Turnover per employee |
9,388
|
8,690
|
9,449 |
| Profit as a percentage of turnover |
3.9%
|
7.9%
|
1.8% |
| Return on assets (ROA) |
4.1%
|
7.2%
|
3.7% |
| Current ratio |
238.8%
|
193.0%
|
285.2% |
| Return on equity (ROE) |
16.3%
|
39.0%
|
16.8% |
| Change turnover |
-11,038
|
-104,412
|
190,743 |
| Change turnover % |
-3%
|
-24%
|
78% |
| Chg. No. of employees |
-4
|
-8
|
6 |
| Chg. No. of employees % |
-11%
|
-17%
|
15% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.